Document is current
Any future updates will be listed below
-
Authors
Edwards, Aled M. https://orcid.org/0000-0002-4782-6016
Owen, Dafydd R. https://orcid.org/0000-0003-3106-7809
,
Zhang, Leili
Young, Damian W.
Willson, Timothy M.
Wellnitz, James
Wang, Yanli
Walsh, Jarrod
Vernet, Erik
Tropsha, Alexander
Tredup, Claudia
Todd, Matthew H.
Tjaden, Amelia
Thamm, Sven
Sundström, Michael
Steffen, Andreas
Stauffer, Shaun
de Souza, Lucas Rodrigo
Shen, Min
Schütt, Kristof
Schiavone, Lovisa Holmberg
Schapira, Matthieu
Santhakumar, Santha
Saikatendu, Kumar
Rivers, Emma
Petrović, Dušan
Peng, Hui
O’Donnell, John P.
Müller-Knapp, Susanne
Mueller-Fahrnow, Anke
Morgan, Maxwell R.
Montel, Florian
Mobarec, Juan Carlos
Michel, Maurice
Melliou, Sofia
Lessel, Uta
Leach, Andrew R.
Krämer, Oliver
Krieger, Florian
Knapp, Stefan
Keefe, Anthony
Kannt, Aimo
Johnson, Scott A.
Häberle, Sandra
Holzinger, Emily Rose
Hartung, Ingo V.
Harding, Rachel J.
Hanke, Thomas
Halabelian, Levon
Haibe-Kains, Benjamin
Günther, Judith
Guié, Marie-Aude
Gordijo, Claudia
Gileadi, Opher
Foschini, Luca
Fernández-Montalván, Amaury
Engkvist, Ola
Edwards, Madison M.
Duerr, Katharina
Drewry, David
Dou, Dengfeng
Djordjevic, Snezana
Diaz, Alejandra Solache
Martinez Cuesta, Sergio
Counago, Rafael
Cornell, Wendy D.
Coker, Jesse A.
Clevert, Djork-Arné
Cernak, Timothy
Burgess-Brown, Nicola A.
Brown, Peter J.
Bengtson, Mario H.
Bashore, Frances M.
Barsyte-Lovejoy, Dalia
Baghaie, Arrash J.
Axtman, Alison D.
Arrowsmith, Cheryl
Antolin, Albert A.
Ackloo, Suzanne
- License Information
-
More Information
Article History
Accepted: 10 June 2025
First Online: 23 July 2025
Competing interests
: D.-A.C., K.S. and D.R.O. are shareholders in Pfizer Inc. The Cernak Lab’s research has been supported by MilliporeSigma, Johnson & Johnson, Relay Therapeutics, Merck & Co., Inc., SPT Labtech, National Defense Medical Center, Shanghai University of Traditional Chinese Medicine, Ministry of Education Taiwan, and Entos, Inc. T.C. has consulted for the University of Dundee Drug Discovery Unit, Scorpion Therapeutics, Relay Therapeutics, Amgen, Genentech, Janssen, Pfizer, Vertex, MilliporeSigma, the US Food & Drug Administration, Gilead, AbbVie, Corteva, Syngenta, Firmenich, Biogen, Bayer, UCB Biopharma, National Taiwan University, AstraZeneca, Grunenthal, and Iambic Therapeutics (previously known as Entos, Inc.). He holds equity in Scorpion Therapeutics and is a co-founder and equity holder at Iambic Therapeutics. B.H.-K. is a co-Founder of the MAQC (Massive Analysis and Quality Control) Society and part of the Scientific Advisory Board of: Consortium de recherche biopharmaceutique (CQDM), Quebec, Canada, Break Through Cancer, Commonwealth Cancer Consortium, United States, Canadian Institute of Health Research–Institute of Genetics, Canada, Cancer Grand Challenges, United Kingdom, Shriners Children, United States. He is part of the Executive Committee of the Terry Fox Digital Health and Discovery Platform, Canada and in the Board of Directors of AACR International–Canada, The American Association for Cancer Research, United States. D.W.Y. is co-founder and shareowner of Deliver Therapeutics. I.V.H. is part of the Board of Directors of TenAces Biosciences. A.K. serves on the SAB of Cilcare, Sulfateq BV and Heartbeat.bio. J.C.M. may hold stock options in Astrazeneca. A.M.-F. is the Board Chair of SGC and Conscience. She is also a shareholder for Bayer AG and an external consultant for Nuvisan ICB GmbH. N.B.-B. is on the SAB for Oxford Vacmedix and holds shares of Exact Sciences. A.T. is co-founder of Predictive LLC. A.S.D. holds stocks in DANAHER. F.K. is a shareholder in Evotec SE. A.F.-M. possess Bayer AG shares. A.A.A. is a consultant to Darwin Health and has received grant funding from Vivan Therapeutics and AtG Therapeutics. D.P. holds stock in Novartis.
